Cited by 133SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRenin-Angiotensin System Studies

Little to no expression of angiotensin‐converting enzyme‐2 on most human peripheral blood immune cells but highly expressed on tissue macrophages

Open access
Song, Xiang, Hu, Wei, Yu, Haibo, Zhao, Laura, Zhao, Yeqian, Zhao, Xin, Xue, Hai‐Hui, Zhao, Yong·2023·Cytometry Part A

Abstract

Angiotensin‐converting enzyme‐2 (ACE2) has been recognized as the binding receptor for the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Flow cytometry demonstrated that there was little to no expression of ACE2 on most of the human peripheral blood‐derived immune cells including CD4+ T, CD8+ T, activated CD4+/CD8+ T, Tregs, Th17, NKT, B, NK cells, monocytes, dendritic cells, and granulocytes. There was no ACE2 expression on platelets and very low level of ACE2 protein expression on the surface of human primary pulmonary alveolar epithelial cells. The ACE2 expression was markedly upregulated on the activated type 1 macrophages (M1). Immunohistochemistry demonstrated high expressions of ACE2 on human tissue macrophages, such as alveolar macrophages, Kupffer cells within livers, and microglial cells in brain at steady state. The data suggest that alveolar macrophages, as the frontline immune cells, may be directly targeted by the SARS‐CoV‐2 infection and therefore need to be considered for the prevention and treatment of COVID‐19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cyto.a.24285

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ACE2 is expressed primarily on activated tissue macrophages but not on peripheral blood mononuclear cells in healthy people.

    “In a study examining the prevalence of ACE2 on immune cells, it was found to be expressed primarily on activated tissue macrophages but not on peripheral blood mononuclear cells in healthy people.”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [28]

    Section 3.5 reports high ACE2 expression on tissue macrophages from normal adult donors, while Section 3.4 reports increased expression on activated M1 macrophages generated from blood monocytes. The paper does not establish that the tissue macrophages were activated. Its PBMC results report little to no ACE2 expression on most immune-cell types from healthy donors, rather than none on all PBMCs; page numbers are not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • ACE2, TMPRSS2, NRP1, integrins, and cathepsins are also expressed on mast cells.

    “ACE2, TMPRSS2, NRP1, integrins, and cathepsins are also expressed on mast cells (Figure 1), 28,29”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [28]

    The Introduction discusses ACE2, TMPRSS2 and cathepsin B/L as possible SARS-CoV-2 entry factors, while section 3.5 reports ACE2 expression on tissue macrophages. Neither passage addresses their expression on mast cells, and a search for mast cells found no relevant passage. The copy therefore cannot verify the claim about ACE2, TMPRSS2, NRP1, integrins and cathepsins on mast cells. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Huh JR, Littman DR. Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications. Eur J Immunol. 2012;42 (9):2232-7.

Cited by

Sorted by citations

Authors
Song, X., Hu, W., Yu, H., Zhao, L., Zhao, Y., Zhao, X., Xue, H., & Zhao, Y.
Affiliations
  • Hackensack Meridian Health (US)
  • Tianhe Stem Cell Biotechnologies Inc. Paramus New Jersey USA
Corresponding author
Zhao, Yong
Venue
Cytometry Part A
Publisher
Wiley
Published
2020-12-16
Volume
103
Issue
2
Pages
136-145
ISSN
  • 1552-4922 (ISSN-L)
  • 1552-4930
OpenAlex
W3113115015
Cited by
117
References
30
Citations by year
2026: 6 · 2025: 6 · 2024: 15 · 2023: 27 · 2022: 33 · 2021: 28 · 2020: 2
FWCI
2.95
Type
journal article
Language
en
Open access
Locations
  • Cytometry Part A (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
angiotensin-converting enzyme 2, ACE2 expression, SARS-CoV-2, COVID-19 pandemic, tissue macrophages, alveolar macrophages, Kupffer cells, microglia, peripheral immune cells, T cells, dendritic cells, platelets, alveolar epithelial cells, M1 macrophages, viral receptor
MeSH terms
Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Angiotensins, Humans, Peptidyl-Dipeptidase A, Macrophages, Alveolar

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review